Evidence map›Paper›PMID 40808528›Full record

Observational studyAnatolian journal of cardiology2025

Results of a Screening Program for Diagnosis of Amyloid Cardiomyopathy Among Patients with Left Ventricular Hypertrophy: PAPCAT Cardiac Amyloidosis Türkiye Survey.

Ebru Özpelit, Yüksel Çavuşoğlu, Gamze Babur Güler, Serkan Ünlü, Özlem Yıldırımtürk, Dilek Çiçek Yılmaz, Cihan Örem, İbrahim Başarıcı, Omaç Tüfekçioğlu, Lale Tokgözoğlu and 21 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Anatolian journal of cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Ebru ÖzpelitDepartment of Cardiology, Dokuz Eylül University, Faculty of Medicine, İzmir, Türkiye.
Yüksel ÇavuşoğluDepartment of Cardiology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Gamze Babur GülerDepartment of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye.
Serkan ÜnlüDepartment of Cardiology, Gazi University Faculty of Medicine, Ankara, Türkiye.
Özlem YıldırımtürkDepartment of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye.
Dilek Çiçek YılmazDepartment of Cardiology, Mersin University Faculty of Medicine, Mersin, Türkiye.
Cihan ÖremDepartment of Cardiology, Karadeniz Technical University Farabi Hospital, Trabzon, Türkiye.
İbrahim BaşarıcıDepartment of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Türkiye.
Omaç TüfekçioğluDepartment of Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
Lale TokgözoğluDepartment of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Uğur Nadir KarakulakDepartment of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
İrem DinçerDepartment of Cardiology, Ankara University Faculty of Medicine, Ankara, Türkiye.
Gamze Çapa KayaDepartment of Nuclear Medicine, Dokuz Eylül University, Faculty of Medicine, İzmir, Türkiye.
İlknur Ak SivriözDepartment of Nuclear Medicine, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Selda MuratDepartment of Cardiology, Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Türkiye.
Arda GülerDepartment of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Türkiye.
Ayşe ÇolakDepartment of Cardiology, Dokuz Eylül University, Faculty of Medicine, İzmir, Türkiye.
Mürsel ŞahinDepartment of Cardiology, Karadeniz Technical University Farabi Hospital, Trabzon, Türkiye.
Elmas KaplanDepartment of Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
Dursun AkaslanDepartment of Cardiology, Marmara University Faculty of Medicine, İstanbul, Türkiye.
Ayçe Türer CabbarDepartment of Cardiology, Yeditepe University Faculty of Medicine, İstanbul, Türkiye.
Murat SünbülDepartment of Cardiology, Marmara University Faculty of Medicine, İstanbul, Türkiye.
Yüksel KayaDepartment of Cardiology, Van Yüzüncü Yıl University Faculty of Medicine, Van, Türkiye.
Cafer Sadık ZorkunDepartment of Cardiology, İstanbul University İstanbul Medical Faculty, İstanbul, Türkiye.
Fahriye Vatansever AğcaDepartment of Cardiology, University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital, Bursa, Türkiye.
Barış İkitimurDepartment of Cardiology, İstanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty, İstanbul, Türkiye.
Alper OnbaşılıDepartment of Cardiology, Aydın Adnan Menderes University Faculty of Medicine, Aydın, Türkiye.
Alev KılıçgedikDepartment of Cardiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
Hakan AltayDepartment of Cardiology, Başkent University İstanbul Hospital, İstanbul, Türkiye.
Elif Eroğlu BüyükönerDepartment of Cardiology, Acıbadem Mehmet Ali Aydinlar University Faculty of Medicine, İstanbul, Türkiye.
Muzaffer DeğertekinDepartment of Cardiology, Yeditepe University Faculty of Medicine, İstanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac amyloidosis (CA) is an increasingly recognized disease. Several recent advanced imaging techniques and parameters have been introduced into the diagnosis of CA. However, the first step in using those techniques is clinical suspicion. Left ventricular hypertrophy (LVH) is the main entity in rising the suspicion of CA in routine echocardiography, although it is not a diagnosis for CA. The aim of this study is to investigate the prevalence of CA and its subtypes and predictive value of clinical and echocardiographic red flags of CA among consecutive adult patients with LVH identified during routine echocardiographic examination in 25 tertiary institutions in Türkiye.

methodsThis was a prospective observational multicenter, national registration study. Patients with LVH (interventricular septum thickness ≥13 mm or >15 mm in those with hypertension) were screened for CA stepwise. The first step was a clinical questionnaire for the red flags of CA. Those having ≥2 red flags were further analyzed by detailed echocardiography, blood tests, Tc-pyrophosphate (PYP) bone scintigraphy, and histopathological examination if needed. Parameters associated with CA were evaluated via univariate and multivariate analyses. Wild-type transthyretin (wTTR) vs. mutant-type TTR (mTTR), CA discriminators were also evaluated in the same manner.

resultsA total of 420 patients meeting these criteria were included in the study. With a standardized algorithmic approach, 27.1% (114) of patients received a CA diagnosis. Among these patients with CA, 50.8% (58) were diagnosed with immunoglobulin free chain (AL) CA, 38.6% (44) with wTTR CA, and 7% (8) with mTTR CA. Left ventricular apical sparing pattern and restrictive type LV filling on echocardiography, low QRS voltage on ECG, bilateral carpal tunnel syndrome, low blood pressure, right ventricular diameter, and an increased basal heart rate (HR) were independent predictors for CA diagnosis. When it comes to diagnosis of wTTR CA; advanced age (age >75), lower troponin values, absence of pericardial effusion and absence of proteinuria were the independent predictors.

conclusionCardiac amyloidosis is highly prevalent in a patient population with LVH and 2 red flags who underwent a standardized algorithmic approach, in which apical sparing, restrictive filling pattern, low QRS voltage, carpal tunnel syndrome, low blood pressure, and increased HR are the highly suggestive signs of CA. Among this pool of newly diagnosed CA patients in Türkiye, AL-CA constituted 50.8%, wTTR CA 38.6%, and mTTR CA 7%, emphasizing that approximately 1 in 2 patients diagnosed with CA may have TTR CA.

Indexed as

AmyloidosisCardiomyopathiesHypertrophy, Left VentricularAdultAgedEchocardiographyFemaleHumansMaleMiddle AgedPrevalenceProspective StudiesTurkey

Identifiers

PMID40808528
PMCPMC12503104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.